Our Innovation Quick read

Biosimilars

As one of the world’s leading innovative biopharmaceutical companies, Pfizer is at the forefront of developing, manufacturing and delivering high-quality biosimilars to patients, physicians, and payers. Biosimilars have the potential to expand patient access to treatment and to create a more sustainable health care system. This should be achieved without compromising quality and by making resources available for further investment and innovation, so that more patients may receive the best possible care.

Read more

Anti-Infectives

Infectious diseases continue to be one of the largest threats to global public health. At Pfizer, we are driven by our desire to protect health and address the medical needs of people suffering from infectious diseases. Starting with our pioneering work on penicillin in the 1940s, we have a long and proud heritage of addressing evolving infectious disease challenges.

Read more

Oncology

Pfizer’s advances in oncology exemplify the power of scientific innovation to transform lives. From immuno-oncology to cell therapy to the continued evolution of personalized medicine, our portfolio and pipeline of cutting-edge therapies aim to change the way the world approaches cancer treatment. We apply that same rigor to meeting the day-to-day emotional, financial and educational needs of these patients in order to help improve their lives in measurable ways.

Read more

Rare Diseases

At Pfizer, we are deeply committed to helping patients suffering from Rare Diseases. One area where Pfizer sees incredible scientific potential is in gene therapy. The technology behind certain gene therapies involves introducing genetic material into the body of a patient to deliver a correct copy of a gene to compensate for a defective or missing one. We are working to explore the promise of gene therapy by leveraging our growing expertise and by making strategic investments, including building dedicated manufacturing facilities, and forging new partnerships and collaborations.

Read more

Vaccines

Pfizer Vaccines is infusing the power of transformative science into disease prevention. Our colleagues are committed to pursuing research and forming partnerships that speed the development and delivery of new, life-saving prophylactic vaccines for bacterial and viral diseases, infectious diseases and even cancer.

Read more

Pipeline

As our understanding of the science and nature of disease evolves, Pfizer strives to address the needs of patients through our extensive portfolio of medicines and vaccines with a keen eye toward the future. Powered by innovative discovery research and development, our scientists take pride in inventing molecules that have the potential to meet patient needs and taking them through rigorous testing and, hopefully, registration and regulatory approval. We have built a broad pipeline of compounds that hold the promise of delivering new, life-changing therapies for a wide range of debilitating and chronic diseases.

Read more

Clinical Trials

Science and innovation are infused into every aspect of Pfizer and our clinical trials are no exception. We are a leader in transforming the way researchers approach clinical trials. We readily embrace cutting-edge technology, strategies and partnerships to ensure our high-quality clinical trials are conducted with speed and agility, and to maximize our ability to bring innovative medicines and vaccines to patients quickly. As technologies evolve, we have a greater opportunity to connect with clinicians, patients and patient advocates in every phase of clinical development, from study design through results reporting, bringing greater insight to the process and reducing the time it takes to move from pre-clinical studies to product approval and availability.

Read more